The nation of Zimbabwe has declined a major US health deal valued at 367 million US dollars (272 million pounds) spanning five years over Washington's insistence on sensitive data.
The decision became public following a internal memorandum dated December was disclosed, indicating that President Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesperson has since stated that the United States was demanding access to biological samples for scientific study and profit while was unwilling to share the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged further talks to find a agreement acceptable to both sides so the nation's critical HIV treatment initiative can continue.
Wider Context
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a high court halted a related health funding agreement after concerns were raised about the security of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump stated its spending was "inefficient" and his administration was pursuing direct bilateral deals to boost openness and accountability.
As per reports, Sixteen African countries have to date agreed to similar health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment through US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information indefinitely, without any equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," he stated.
"In essence, our nation would supply the basic resources for medical research without any certainty that the final treatments would be accessible to our people should a future health crisis emerge."
Sovereignty and Global Health
Mangwana further said that the American exit from the global health body and its pursuit of bilateral deals were undermining structures already set up through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing system created to manage future global health emergencies.
"This mechanism is intended to ensure that when a country contributes its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage continued discussions with our American counterparts on how subsequent collaboration might be arranged in a way that honours the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but suggested that negotiations need to persist considering a large portion of the country's HIV programmes relied on external financing.
"Where specific concerns exist, including those involving data governance or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," the group commented.
This impasse emphasises the complex tensions between receiving crucial foreign assistance and protecting national sovereignty in an ever more interconnected world.